Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
about
Novel Drugs and Combination Therapies for the Treatment of Metastatic MelanomaTargeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaConsensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.Hairy cell leukemia: update and current therapeutic approach.Potential breakthroughs with investigational drugs for hairy cell leukemia.An extremely rare case of concurrent BRAF V600E mutation driven hairy cell leukemia and melanoma: case report and review of literature.Concomitant Non-Small Cell Lung Cancer and Hairy Cell Leukemia in a Patient Harboring BRAF-V600E Mutation in Both Tissues: A Case Report.
P2860
Q26772015-3E108C40-2E6A-4FF0-82D5-B0A6C646D400Q27853209-C6346AB1-C5A2-4148-B3E7-541046682642Q37623386-FDBB2013-6DFA-4025-975A-F69F65CB7B74Q38518290-FD2E9BF8-DB67-4685-B583-8CC258610983Q38578492-44841A46-BD8B-4FA5-A761-C001A09CC1B8Q42373884-C384ADA5-719E-401A-BB6D-42D24DD3E038Q55363708-61331752-39AB-41BA-9AFB-D412D60527EF
P2860
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
@en
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
@nl
type
label
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
@en
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
@nl
prefLabel
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
@en
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
@nl
P2093
P356
P1476
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib
@en
P2093
David M Lucas
Gerard Lozanski
Kari Kendra
Leslie A Andritsos
Michael R Grever
P304
9-13; quiz 13
P356
10.6004/JNCCN.2015.0004
P577
2015-01-01T00:00:00Z